Efficacy and Safety of Apatinib in Advanced Hepatocellular Carcinoma: A Multicenter Real World Retrospective Study

Background and Purpose: Apatinib is a novel antiangiogenic agent that can target vascular endothelial cell growth factor 2. The aim of our study was to evaluate the efficacy and safety of apatinib mesylate in the treatment of advanced hepatocellular carcinoma (HCC) in the real world. Methods: We ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Zhuangzhuang, Liu, Zijing, Zhang, Haifeng, Guo, Xiao, Jia, Xiaojing, Wang, Jianfeng, Meng, Lingbin, Xin, Ying, Jiang, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152289/
https://www.ncbi.nlm.nih.gov/pubmed/35656302
http://dx.doi.org/10.3389/fphar.2022.894016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152289/
https://www.ncbi.nlm.nih.gov/pubmed/35656302
http://dx.doi.org/10.3389/fphar.2022.894016

Ejemplares similares